[日本語] English
文献
- EMDB/PDB/SASBDBから引用されている文献のデータベース -

+
検索条件

キーワード
構造解析手法
著者・登録者
ジャーナル
IF

-
Structure paper

タイトルPredictive features of ligand-specific signaling through the estrogen receptor.
ジャーナル・号・ページMol. Syst. Biol., Vol. 12, Page 864-864, Year 2016
掲載日2015年5月4日 (構造データの登録日)
著者Nwachukwu, J.C. / Srinivasan, S. / Zheng, Y. / Wang, S. / Min, J. / Dong, C. / Liao, Z. / Nowak, J. / Wright, N.J. / Houtman, R. ...Nwachukwu, J.C. / Srinivasan, S. / Zheng, Y. / Wang, S. / Min, J. / Dong, C. / Liao, Z. / Nowak, J. / Wright, N.J. / Houtman, R. / Carlson, K.E. / Josan, J.S. / Elemento, O. / Katzenellenbogen, J.A. / Zhou, H.B. / Nettles, K.W.
リンクMol. Syst. Biol. / PubMed:27107013
手法X線回折
解像度1.771 - 2.863 Å
構造データ

PDB-4zn7:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Diethylstilbestrol
手法: X-RAY DIFFRACTION / 解像度: 1.934 Å

PDB-4znh:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substituted OBHS derivative
手法: X-RAY DIFFRACTION / 解像度: 1.933 Å

PDB-4zns:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Fluoro-substituted OBHS derivative
手法: X-RAY DIFFRACTION / 解像度: 1.86 Å

PDB-4znt:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Bromo-substituted OBHS derivative
手法: X-RAY DIFFRACTION / 解像度: 1.903 Å

PDB-4znu:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methyl-substituted OBHS derivative
手法: X-RAY DIFFRACTION / 解像度: 2.4 Å

PDB-4znv:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substituted OBHS derivative
手法: X-RAY DIFFRACTION / 解像度: 1.771 Å

PDB-4znw:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 4-Bromo-substituted OBHS derivative
手法: X-RAY DIFFRACTION / 解像度: 2.31 Å

PDB-5di7:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with an methyl-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-(4-hydroxy-2-methylphenyl)-7a-methyloctahydro-1H-inden-1-ol
手法: X-RAY DIFFRACTION / 解像度: 2.241 Å

PDB-5did:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a difluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-(2,3-difluoro-4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5die:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5dig:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoromethyl-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-[4-hydroxy-2-(trifluoromethyl)phenyl]-7a-methyloctahydro-1H-inden-1-ol
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5dk9:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-{2-[3-(phenylamino)phenyl]but-1-ene-1,1-diyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.28 Å

PDB-5dkb:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.4 Å

PDB-5dke:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, methyl, cis-diaryl-ethylene compound 4,4'-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.6 Å

PDB-5dkg:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.15 Å

PDB-5dks:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substituted, ethyl, triaryl-ethylene derivative 4,4'-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.6 Å

PDB-5dl4:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted, methyl, triaryl-ethylene derivative 4,4'-{2-[3-(phenylamino)phenyl]prop-1-ene-1,1-diyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.1 Å

PDB-5dlr:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound 4,4'-(2-phenylethene-1,1-diyl)diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.26 Å

PDB-5dmc:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a nitrile-substituted triaryl-ethylene derivative 3,3-bis(4-hydroxyphenyl)-2-phenylprop-2-enenitrile
手法: X-RAY DIFFRACTION / 解像度: 2.403 Å

PDB-5dmf:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted, methyl triaryl-ethylene derivative 4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}prop-1-ene-1,1-diyl)diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.4 Å

PDB-5dp0:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted triaryl-ethylene derivative 4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.382 Å

PDB-5drj:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3-methyl 2,5-diarylthiophene-core ligand 4,4'-(3-methylthiene-2,5-diyl)bis(3-chlorophenol)
手法: X-RAY DIFFRACTION / 解像度: 2.07 Å

PDB-5drm:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4'-thiene-2,5-diylbis(3-chlorophenol)
手法: X-RAY DIFFRACTION / 解像度: 2.241 Å

PDB-5dtv:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dimethyl-substituted, 3,4-diarylthiophene dioxide core ligand
手法: X-RAY DIFFRACTION / 解像度: 2.295 Å

PDB-5du5:
Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3,4-diarylthiophene dioxide core ligand
手法: X-RAY DIFFRACTION / 解像度: 2.195 Å

PDB-5due:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a para-Hydroxyl-substituted, Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 Analog 4-hydroxyphenyl (1S,2S,4S,5S,6R,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]heptane-2-sulfonate 7-oxide
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-5dug:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide
手法: X-RAY DIFFRACTION / 解像度: 2.252 Å

PDB-5duh:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5dvs:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Methyl-substituted Triaryl-imine 4,4'-[(2-methylphenyl)carbonimidoyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.28 Å

PDB-5dvv:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4'-(phenylcarbonimidoyl)diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.505 Å

PDB-5dwe:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Chloro-substituted Triaryl-imine analog 4,4'-[(2-chlorophenyl)carbonimidoyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 1.92 Å

PDB-5dwg:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Triaryl-substituted Imine Analog, 4-{(E)-(4-hydroxyphenyl)[(2-methylphenyl)imino]methyl}benzene-1,3-diol
手法: X-RAY DIFFRACTION / 解像度: 2.3 Å

PDB-5dwi:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-substituted Diaryl-imine analog 4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol
手法: X-RAY DIFFRACTION / 解像度: 2.43 Å

PDB-5dwj:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-substituted Diaryl-imine analog 4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol
手法: X-RAY DIFFRACTION / 解像度: 2.001 Å

PDB-5dxk:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(9s)-bicyclo[3.3.1]non-9-ylmethanediyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.226 Å

PDB-5dxm:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol
手法: X-RAY DIFFRACTION / 解像度: 2.37 Å

PDB-5dxp:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol
手法: X-RAY DIFFRACTION / 解像度: 2.201 Å

PDB-5dxq:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.4 Å

PDB-5dxr:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3R)-3-methylcyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.28 Å

PDB-5dy8:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.031 Å

PDB-5dyb:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.27 Å

PDB-5dyd:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.485 Å

PDB-5dz0:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5dz1:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4-ethylcyclohexylidene)methanediyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.2 Å

PDB-5dz3:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(fluoromethyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.15 Å

PDB-5dzh:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.11 Å

PDB-5dzi:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 1.9 Å

PDB-5e0w:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5e0x:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(4-methoxyphenyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.014 Å

PDB-5e14:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3R)-3-phenylcyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.22 Å

PDB-5e15:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.1 Å

PDB-5e19:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate
手法: X-RAY DIFFRACTION / 解像度: 2.24 Å

PDB-5e1c:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative dimethyl {(1S)-3-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}propanedioate
手法: X-RAY DIFFRACTION / 解像度: 1.98 Å

PDB-5egv:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan derivative 3-chloranyl-4-[4-(2-chloranyl-4-oxidanyl-phenyl)furan-3-yl]phenol
手法: X-RAY DIFFRACTION / 解像度: 2.863 Å

PDB-5ehj:
Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol
手法: X-RAY DIFFRACTION / 解像度: 2.5 Å

PDB-5ei1:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine derivative 2-(4-hydroxyphenyl)-3-iodanyl-imidazo[1,2-a]pyridin-6-ol
手法: X-RAY DIFFRACTION / 解像度: 2.4 Å

PDB-5eit:
Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine derivative 2-(4-hydroxyphenyl)-3-(trifluoromethyl)imidazo[1,2-a]pyridin-6-ol
手法: X-RAY DIFFRACTION / 解像度: 2.68 Å

化合物

ChemComp-DES:
DIETHYLSTILBESTROL / ジエチルスチルベストロ-ル / 薬剤, ホルモン*YM

ChemComp-HOH:
WATER

ChemComp-OBC:
2-fluorophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate

ChemComp-OFB:
3-fluorophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate

ChemComp-OBB:
3-bromophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate

ChemComp-4Q9:
2-methylphenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate

ChemComp-4Q7:
2-methoxyphenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate

ChemComp-OBM:
4-bromophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate

ChemComp-5CQ:
(1S,3aR,5S,7aS)-5-(4-hydroxy-2-methylphenyl)-7a-methyloctahydro-1H-inden-1-ol

ChemComp-5CK:
(1S,3aR,5S,7aS)-5-(2,3-difluoro-4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol

ChemComp-5CJ:
(1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol

ChemComp-5CE:
(1S,3aR,5S,7aS)-5-[4-hydroxy-2-(trifluoromethyl)phenyl]-7a-methyloctahydro-1H-inden-1-ol

ChemComp-5CC:
4,4'-{2-[3-(phenylamino)phenyl]but-1-ene-1,1-diyl}diphenol

ChemComp-5C9:
4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol

ChemComp-5C8:
4,4'-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol

ChemComp-5C7:
4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol

ChemComp-5C6:
4,4'-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol

ChemComp-5C4:
4,4'-{2-[3-(phenylamino)phenyl]prop-1-ene-1,1-diyl}diphenol

ChemComp-5DJ:
4,4'-(2-phenylethene-1,1-diyl)diphenol

ChemComp-5DH:
3,3-bis(4-hydroxyphenyl)-2-phenylprop-2-enenitrile / 2-フェニル-3,3-ビス(4-ヒドロキシフェニル)プロペンニトリル

ChemComp-5DG:
4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}prop-1-ene-1,1-diyl)diphenol

ChemComp-5ES:
4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol

ChemComp-5EU:
4,4'-(3-methylthiene-2,5-diyl)bis(3-chlorophenol)

ChemComp-5ET:
4,4'-thiene-2,5-diylbis(3-chlorophenol)

ChemComp-5FS:
3,4-bis(4-hydroxy-2-methylphenyl)-1H-1lambda~6~-thiophene-1,1-dione

ChemComp-5G2:
3,4-bis(2-chloro-4-hydroxyphenyl)-1H-1lambda~6~-thiophene-1,1-dione

ChemComp-5FY:
4-hydroxyphenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide

ChemComp-5FV:
phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide

ChemComp-5FT:
phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide

ChemComp-5G7:
4,4'-[(2-methylphenyl)carbonimidoyl]diphenol

ChemComp-5G6:
4,4'-(phenylcarbonimidoyl)diphenol

ChemComp-5G5:
4,4'-[(2-chlorophenyl)carbonimidoyl]diphenol

ChemComp-5G4:
4-{(E)-(4-hydroxyphenyl)[(2-methylphenyl)imino]methyl}benzene-1,3-diol

ChemComp-5G3:
4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol

ChemComp-5J2:
4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol

ChemComp-5J1:
4,4'-[(9s)-bicyclo[3.3.1]non-9-ylmethanediyl]diphenol

ChemComp-5J0:
3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol

ChemComp-5HX:
4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol

ChemComp-5HZ:
4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol

ChemComp-5HW:
4,4'-{[(3R)-3-methylcyclohexylidene]methanediyl}diphenol

ChemComp-5K4:
4,4'-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol

ChemComp-5K2:
4,4'-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol

ChemComp-5K1:
4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol

ChemComp-5K0:
4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol

ChemComp-5JY:
4,4'-[(4-ethylcyclohexylidene)methanediyl]diphenol

ChemComp-5JX:
4,4'-{[4-(fluoromethyl)cyclohexylidene]methanediyl}diphenol

ChemComp-5KG:
4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol

ChemComp-5KF:
4,4'-{[(3S)-3-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol

ChemComp-5KE:
4,4'-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol

ChemComp-5KD:
4,4'-{[(3S)-3-(4-methoxyphenyl)cyclohexylidene]methanediyl}diphenol

ChemComp-5KB:
4,4'-{[(3R)-3-phenylcyclohexylidene]methanediyl}diphenol

ChemComp-5KA:
4,4'-({4-[2-(4-fluorobutoxy)ethyl]cyclohexylidene}methanediyl)diphenol

ChemComp-5K7:
methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate

ChemComp-5K8:
dimethyl {(1S)-3-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}propanedioate

ChemComp-5OS:
3-chloranyl-4-[4-(2-chloranyl-4-oxidanyl-phenyl)furan-3-yl]phenol

ChemComp-5K5:
4,4'-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol

ChemComp-5OR:
2-(4-hydroxyphenyl)-3-iodanyl-imidazo[1,2-a]pyridin-6-ol

ChemComp-5P1:
2-(4-hydroxyphenyl)-3-(trifluoromethyl)imidazo[1,2-a]pyridin-6-ol

由来
  • homo sapiens (ヒト)
キーワードTRANSCRIPTION / Nuclear receptor Transcription factor Nucleus protein-ligand complex / Nuclear receptor / transcription factor / ligand binding / protein-ligand complex

+
万見文献について

-
お知らせ

-
2022年2月9日: EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

  • EMDBのヘッダファイルのバージョン3が、公式のフォーマットとなりました。
  • これまでは公式だったバージョン1.9は、アーカイブから削除されます。

関連情報:EMDBヘッダ

外部リンク:wwPDBはEMDBデータモデルのバージョン3へ移行します

-
2020年8月12日: 新型コロナ情報

新型コロナ情報

URL: https://pdbj.org/emnavi/covid19.php

新ページ: EM Navigatorに新型コロナウイルスの特設ページを開設しました。

関連情報:Covid-19情報 / 2020年3月5日: 新型コロナウイルスの構造データ

+
2020年3月5日: 新型コロナウイルスの構造データ

新型コロナウイルスの構造データ

関連情報:万見生物種 / 2020年8月12日: 新型コロナ情報

外部リンク:COVID-19特集ページ - PDBj / 今月の分子2020年2月:コロナウイルスプロテーアーゼ

+
2019年1月31日: EMDBのIDの桁数の変更

EMDBのIDの桁数の変更

  • EMDBエントリに付与されているアクセスコード(EMDB-ID)は4桁の数字(例、EMD-1234)でしたが、間もなく枯渇します。これまでの4桁のID番号は4桁のまま変更されませんが、4桁の数字を使い切った後に発行されるIDは5桁以上の数字(例、EMD-12345)になります。5桁のIDは2019年の春頃から発行される見通しです。
  • EM Navigator/万見では、接頭語「EMD-」は省略されています。

関連情報:Q: 「EMD」とは何ですか? / 万見/EM NavigatorにおけるID/アクセスコードの表記

外部リンク:EMDB Accession Codes are Changing Soon! / PDBjへお問い合わせ

+
2017年7月12日: PDB大規模アップデート

PDB大規模アップデート

  • 新バージョンのPDBx/mmCIF辞書形式に基づくデータがリリースされました。
  • 今回の更新はバージョン番号が4から5になる大規模なもので、全エントリデータの書き換えが行われる「Remediation」というアップデートに該当します。
  • このバージョンアップで、電子顕微鏡の実験手法に関する多くの項目の書式が改定されました(例:em_softwareなど)。
  • EM NavigatorとYorodumiでも、この改定に基づいた表示内容になります。

外部リンク:wwPDB Remediation / OneDepデータ基準に準拠した、より強化された内容のモデル構造ファイルが、PDBアーカイブで公開されました。

-
万見文献

EMDB/PDB/SASBDBから引用されている文献のデータベース

  • EMDB/PDB/SASBDBのエントリから引用されている文献のデータベースです
  • Pubmedのデータを利用しています

関連情報:EMDB / PDB / SASBDB / 万見 (Yorodumi) / EMN文献 / 新しいEM Navigatorと万見の変更点

他の情報も見る